https://www.biomarkdiagnostics.com/biomark-diagnostics-endorses-global-call-for-equitable-access-to-early-screening-on-2026-world-lung-cancer-day/ 2026-09-08T08:05:36+00:00 https://www.biomarkdiagnostics.com/biomarks-metabolomics-platform-captures-global-scientific-interest-following-publications-demonstrating-superior-diagnostic-performance-and-cost-efficiency-for-liquid-biopsy/ 2026-09-08T08:03:55+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-june-2026/ 2026-07-13T06:46:59+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-may-2026/ 2026-07-13T06:43:27+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-secures-landmark-canadian-and-european-patent-allowances-for-early-stage-lung-cancer-blood-test/ 2026-07-13T06:37:51+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-april-2026/ 2026-07-13T06:35:47+00:00 https://www.biomarkdiagnostics.com/biomark-secures-broad-u-s-patent-for-urine-based-lung-cancer-screening-expanding-differentiated-liquid-biopsy-testing-platform/ 2026-06-11T09:02:02+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-march-2026/ 2026-05-05T08:49:16+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-to-present-liquid-biopsy-platform-at-the-canadian-thoracic-society-research-forum/ 2026-04-14T18:07:58+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-february-2026/ 2026-03-04T18:30:34+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-january-2026/ 2026-02-07T08:08:38+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-december-2025-2/ 2026-02-07T08:08:08+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-announces-publication-of-peer-reviewed-validation-of-machine-learning-models-for-lung-cancer-detection-in-frontiers-in-oncology/ 2026-01-18T17:06:18+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-announces-appointment-of-mr-james-lavender-to-board-of-directors/ 2026-01-03T08:05:14+00:00 https://www.biomarkdiagnostics.com/biomark-2025-achievements-2026-vision/ 2026-01-03T08:02:37+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-advances-commercialization-strategy-by-initiating-iso-15189-accreditation-program/ 2025-12-24T09:49:53+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-collaborative-lung-cancer-screening-project-honored-by-adriq-during-the-35th-innovation-awards-gala/ 2025-12-03T09:07:11+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-november-2025/ 2025-12-03T09:04:23+00:00 https://www.biomarkdiagnostics.com/biomark-aligns-with-national-strategy-to-slash-lung-cancer-mortality-with-next-gen-liquid-biopsy/ 2025-11-14T08:20:51+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-october-2025/ 2025-11-04T20:16:32+00:00 https://www.biomarkdiagnostics.com/biomarks-liquid-biopsy-platform-selected-for-holistic-german-lung-cancer-screening-trial/ 2025-10-08T17:49:22+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-september-2025/ 2025-10-08T17:46:38+00:00 https://www.biomarkdiagnostics.com/biomark-patent-asia-lung-cancer/ 2025-10-01T08:11:22+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-july-2025/ 2025-09-07T08:09:14+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-june-2025/ 2025-09-07T08:08:58+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-august-2025/ 2025-09-07T08:07:39+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-establishes-african-market-presence-through-strategic-tunisia-healthcare-partnership/ 2025-08-12T06:42:17+00:00 https://www.biomarkdiagnostics.com/press-release-biomark-diagnostics-announces-expansion-of-its-specialty-laboratory-services-in-quebec-to-accommodate-increased-demand-from-international-partnerships/ 2025-08-11T07:41:17+00:00 https://www.biomarkdiagnostics.com/press-release-biomark-diagnostics-highlights-fiscal-year-2025-achievements-and-sets-bold-strategic-milestones-for-2025-2026/ 2025-08-11T07:39:13+00:00 https://www.biomarkdiagnostics.com/press-release-biomark-diagnostics-announces-breakthrough-publication-reinforcing-leadership-in-ai-powered-metabolomics-for-oncology/ 2025-06-03T07:29:22+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-may-2025/ 2025-06-03T07:26:01+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-announces-landmark-publication-validating-high-specificity-and-accuracy-of-its-early-stage-lung-cancer-test/ 2025-05-13T07:22:54+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-announces-uplisting-to-otcqb-venture-market/ 2025-05-10T07:47:05+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-april-2025/ 2025-05-06T15:49:48+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-march-2025/ 2025-04-06T06:28:31+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-october-2024/ 2025-04-06T06:21:34+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-november-2024-2/ 2025-04-06T06:21:17+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-december-2025/ 2025-04-06T06:20:59+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-january-2025-2/ 2025-04-06T06:20:41+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-february-2025-2/ 2025-04-06T06:20:21+00:00 https://www.biomarkdiagnostics.com/biomark-announces-the-final-closing-of-oversubscribed-private-placement/ 2025-04-02T06:12:22+00:00 https://www.biomarkdiagnostics.com/biomark-secures-financing-for-initial-tranche-to-advance-early-detection-oncology-testing-platform/ 2025-03-26T17:18:37+00:00 https://www.biomarkdiagnostics.com/remembering-mia-love-a-trailblazers-legacy-and-biomarks-fight-against-cancer/ 2025-03-26T14:00:16+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2025/03/official-congressional-photo-of-mia-love-who-passed-from-glioblastoma-early-cancer-detection-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/biomark-diagnostics-underscores-commitment-to-rare-diseaseresearch-on-rare-disease-day-2025/ 2025-03-05T11:24:16+00:00 https://www.biomarkdiagnostics.com/from-black-plastics-to-biomarkers-how-environmental-causes-of-cancer-can-be-prevented/ 2025-02-11T04:09:00+00:00 https://www.biomarkdiagnostics.com/cancer-is-rising-among-women-early-detection-of-lung-cancer/ 2025-02-03T16:06:00+00:00 https://www.biomarkdiagnostics.com/cancer-prevention-5-actionable-steps/ 2025-01-27T16:10:00+00:00 https://www.biomarkdiagnostics.com/biomarks-liquid-biopsy-platform-takes-a-major-step-forward-in-breast-cancer-diagnosiswith-ai-powered-er-status-prediction/ 2024-12-11T10:55:53+00:00 https://www.biomarkdiagnostics.com/biomark-expands-its-liquid-biopsy-platform-with-two-groundbreaking-publications-in-breast-cancer-detection/ 2024-11-06T06:30:41+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-september-2024/ 2024-10-04T05:11:34+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-and-principal-investigators-publish-an-important-approach-using-metabolomics-and-ml-to-identify-biomarkers-for-nen/ 2024-10-01T08:24:22+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-completes-testing-of-over-5400-subjects-as-part-of-a-validation-study-for-early-lung-cancer-detection/ 2024-09-12T06:36:26+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-to-showcase-innovative-liquid-biopsy-technology-at-h-c-wainwrights-26th-annual-global-investment-conference-in-new-york/ 2024-09-02T05:40:06+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-august-2024/ 2024-09-02T05:33:57+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-july-2024/ 2024-08-04T18:17:30+00:00 https://www.biomarkdiagnostics.com/the-u-s-patent-and-trademark-office-grants-biomark-patent-that-expands-its-claims-covering-its-legacy-liquid-biopsy-assay/ 2024-08-04T18:13:36+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-announces-presentation-of-promising-glioblastoma-research-at-2024-gpen-conference/ 2024-07-17T05:16:54+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-june-2024/ 2024-07-07T05:42:30+00:00 https://www.biomarkdiagnostics.com/a-day-to-honour-dr-daniel-sitar-fellowship-of-the-society-of-pharmacology-and-therapeutics/ 2024-07-01T08:14:30+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2024/07/dr-daniel-sitar.jpg https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-may-2024/ 2024-06-03T05:58:39+00:00 https://www.biomarkdiagnostics.com/the-global-breast-cancer-screening-crisis-how-liquid-biopsies-can-bridge-the-divide/ 2024-05-17T07:25:36+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2024/05/a-nurse-holding-a-liquid-biopsy-breast-cancer-sample-in-a-sealed-vial-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/biomark-diagnostics-rashid-ahmen.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2024/05/scientist-and-lab-technician-study-a-liquid-biopsy-for-breast-cancer-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/biomark-announces-warrant-extension-and-granting-of-options/ 2024-05-06T09:58:32+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-april-2024/ 2024-05-06T09:50:39+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-march-2024/ 2024-05-06T09:46:38+00:00 https://www.biomarkdiagnostics.com/biomark-to-advance-development-of-cancer-treatment-for-glioblastoma/ 2024-04-09T15:42:52+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-february-2024/ 2024-03-05T13:54:46+00:00 https://www.biomarkdiagnostics.com/biomark-partners-with-rubix-ls-to-advance-blood-based-cancer-screening-in-underserved-communities/ 2024-02-28T20:52:51+00:00 https://www.biomarkdiagnostics.com/theresa-peterson-joins-biomarks-advisory-team/ 2024-02-28T20:43:36+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-january-2024/ 2024-02-04T16:11:00+00:00 https://www.biomarkdiagnostics.com/insightscare-interview-biomark-diagnostics-inc-innovating-cancer-detection/ 2024-01-11T07:31:02+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2024/01/Rashid-A-Bux-CEO-and-Founder-BioMark-Diagnostics-Inc.jpg https://www.biomarkdiagnostics.com/biomark-announces-closing-of-1-9-million-non-brokered-private-placement/ 2024-01-11T07:18:19+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-december-2023/ 2024-01-11T07:15:34+00:00 https://www.biomarkdiagnostics.com/biomark-announces-recent-new-patent-granted-in-canada-to-support-its-liquid-biopsy-based-legacy-assay/ 2023-12-05T07:16:36+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-november-2023/ 2023-12-05T07:14:21+00:00 https://www.biomarkdiagnostics.com/biomark-provides-second-quarter-operational-update-and-announces-extension-to-warrant-exercise-term/ 2023-11-28T17:54:36+00:00 https://www.biomarkdiagnostics.com/biomark-strengthens-and-expands-its-strategic-advisory-team-in-pursuit-of-commercialization-initiatives/ 2023-11-22T18:54:56+00:00 https://www.biomarkdiagnostics.com/biomark-announces-financial-contribution-from-the-city-of-quebec-to-support-commercialization-initiatives-of-its-proprietary-lung-cancer-detection-test/ 2023-11-08T09:14:27+00:00 https://www.biomarkdiagnostics.com/biomark-to-unveil-results-of-its-early-breast-cancer-study-at-the-upcoming-san-antonio-breast-cancer-symposium/ 2023-11-08T09:11:40+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-october-2023/ 2023-11-08T09:04:05+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-september-2023/ 2023-11-08T08:57:30+00:00 https://www.biomarkdiagnostics.com/une-technologie-dici-pour-mieux-diagnostiquer-le-cancer-du-poumon-local-technology-for-improved-lung-cancer-diagnosis/ 2023-09-10T09:51:16+00:00 https://www.biomarkdiagnostics.com/biomark-appoints-kevin-j-cosgriff-to-its-strategic-advisory-team/ 2023-09-10T09:32:35+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-august-2023/ 2023-09-10T09:30:08+00:00 https://www.biomarkdiagnostics.com/japan-patent-office-jpo-issuedd-biomark-patent-with-claims-covering-its-lung-cancer-urine-based-liquid-biopsy-assay/ 2023-08-16T07:22:18+00:00 https://www.biomarkdiagnostics.com/biomark-issues-statement-on-recent-market-activity-and-provides-a-brief-corporate-update/ 2023-08-16T07:18:02+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-july-2023/ 2023-08-16T07:08:57+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-june-2023/ 2023-07-12T12:53:45+00:00 https://www.biomarkdiagnostics.com/biomark-unveils-significant-scientific-advancements-from-its-leading-liquid-biopsy-technology-at-asco-2023-annual-meeting/ 2023-06-13T07:02:28+00:00 https://www.biomarkdiagnostics.com/biomarks-dr-maksymuik-presents-at-prestigous-asco-annual-meeting/ 2023-06-13T06:56:32+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2023/06/ASCO-1-1024x576.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/06/ASCO-3-Dr.-Maksymuik-1024x803.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/06/ASCO-2-1024x768.jpg https://www.biomarkdiagnostics.com/biomark-announces-the-u-s-patent-and-trademark-office-granted-patent-with-claims-covering-its-lung-cancer-liquid-biopsy-assay/ 2023-06-04T09:06:17+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-may-2023/ 2023-06-04T09:03:20+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-april-2023/ 2023-05-17T09:16:26+00:00 https://www.biomarkdiagnostics.com/press-release-biomark-latest-results-accepted-for-presentation-at-the-american-society-of-clinical-oncology-asco-annual-meeting-2023/ 2023-05-17T09:06:26+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-march-2023/ 2023-04-12T18:44:37+00:00 https://www.biomarkdiagnostics.com/biomark-presents-novel-liquid-biopsy-data-in-pulmonary-neuroendocrine-tumors/ 2023-03-22T09:50:06+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-february-2023/ 2023-03-22T09:46:03+00:00 https://www.biomarkdiagnostics.com/biomark-provides-third-quarter-operational-update-and-2023/ 2023-03-03T18:53:44+00:00 https://www.biomarkdiagnostics.com/indigenous-innovator-dr-nadine-carons-quest-for-equity-in-cancer-care-and-research/ 2023-03-06T17:15:00+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/black-history-month-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/dr-nadine-caron-indigenous-innovator.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/indigenous-peoples-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/diversity-in-advanced-medical-research.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/dr-nadine-caron-and-her-important-work-and-research.jpg https://www.biomarkdiagnostics.com/revolutionizing-cancer-research-meet-dr-juliet-daniel-the-trailblazing-black-scientist-making-a-difference-in-the-lives-of-triple-negative-breast-cancer-tnbc-patients/ 2023-02-28T20:31:31+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/breast-cancer-survival-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/dr-juliet-daniel-breast-cancer-research-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/diverisity-in-medicine-and-science-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/biomark-diagnostics-rashid-ahmen.jpg https://www.biomarkdiagnostics.com/breaking-barriers-past-and-current-celebrating-the-legacy-of-dr-clarice-reid-pioneer-in-sickle-cell-research-biomark-diagnostics/ 2023-02-09T16:50:00+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/dr-clarice-reid.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/prejudice-and-racism-dr-reid-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/systemic-barriers-and-discrimination-faced-by-black-women-in-science-and-medicine.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/diverisity-in-medicine-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2023/02/biomark-diagnostics-rashid-ahmen.jpg https://www.biomarkdiagnostics.com/biomark-receives-funding-support-research-and-development-project-for-cancer-treatment-monitoring/ 2023-02-09T04:12:34+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-january-1-2023/ 2023-02-05T18:20:41+00:00 https://www.biomarkdiagnostics.com/biomark-announces-update-from-ongoing-clinical-trial-using-its-lung-cancer-liquid-biospy-test-as-it-prepares-for-commercial-launch/ 2023-01-12T16:46:00+00:00 https://www.biomarkdiagnostics.com/biomark-provides-business-update-and-second-quarter-financial-results/ 2023-01-12T16:25:16+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-november-1-2022/ 2023-01-12T16:24:55+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-december-1-2022/ 2023-01-12T16:24:46+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-october-1-2022/ 2022-11-22T19:49:31+00:00 https://www.biomarkdiagnostics.com/biomarks-glioblastoma-study-published-in-cancers-demonstrates-inhibiting-sat1-sensitized-cancer-cells-towards-radiation-and-chemotherapy/ 2022-10-31T00:55:09+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-september-2022/ 2022-10-03T00:20:14+00:00 https://www.biomarkdiagnostics.com/the-us-patent-office-grants-biomark-additional-patent-for-its-liquid-biopsy-technology/ 2022-09-24T02:24:31+00:00 https://www.biomarkdiagnostics.com/biomark-to-present-validation-data-of-its-multianalyte-metabolite-panel-for-lung-cancer-screening-at-the-esmo-congress-2022/ 2022-09-08T19:28:10+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-august-2022/ 2022-09-08T19:24:58+00:00 https://www.biomarkdiagnostics.com/biomark-selected-by-the-medical-alley-and-investissement-quebec-to-join-the-us-go-to-market-accelerator/ 2022-09-06T17:50:21+00:00 https://www.biomarkdiagnostics.com/biomark-provides-first-quarter-2022-financial-results-and-operational-update/ 2022-09-01T03:18:31+00:00 https://www.biomarkdiagnostics.com/biomark-provides-financial-results-for-the-year-ended-march-31-2022-and-recent-corporate-highlights/ 2022-08-08T14:13:05+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-june-2022/ 2022-08-08T14:08:51+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-progress-report-july-2022/ 2022-08-08T14:07:57+00:00 https://www.biomarkdiagnostics.com/form-7-monthly-cse-progress-report-may-2022/ 2022-07-06T04:08:14+00:00 https://www.biomarkdiagnostics.com/biomark-continues-to-strengthen-its-intellectual-property-position-with-new-patentand-trademark-use-in-canada/ 2022-06-21T15:03:35+00:00 https://www.biomarkdiagnostics.com/biotech-brothers-interview-with-rashid-ahmed-ceo-biomark-diagnostics/ 2022-05-20T18:13:51+00:00 https://www.biomarkdiagnostics.com/press-release-biomark-announces-closing-of-15-million-financing-round-to-accelerate-commercialization-of-its-liquid-biopsy-technology/ 2022-05-05T03:08:46+00:00 https://www.biomarkdiagnostics.com/cse-form-7-monthly-progress-report-biomark-diagnostics-inc-mar-2022/ 2022-05-05T02:55:46+00:00 https://www.biomarkdiagnostics.com/biomark-to-present-new-cancer-screening-data-using-the-ldtd-ms-ms-technique-at-the-annual-asms-conference-on-mass-spectrometry/ 2022-04-29T15:19:09+00:00 https://www.biomarkdiagnostics.com/biomark-monthly-progress-report-april-4-2022/ 2022-04-07T20:46:13+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-to-open-u-s-headquarters-in-maryland/ 2021-08-24T19:33:49+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2015/08/BioMaryland.png https://www.biomarkdiagnostics.com/quest-for-game-changing-lung-cancer-diagnostic-assay/ 2021-08-24T19:22:00+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-presents-at-rodman-renshaw-conference-in-ny-usa/ 2021-08-24T19:17:48+00:00 https://www.biomarkdiagnostics.com/biomark-ceo-interview-with-snnlive-sep-2015/ 2021-08-24T19:11:27+00:00 https://www.biomarkdiagnostics.com/dr-james-bond-on-biomark/ 2021-08-24T19:07:38+00:00 https://www.biomarkdiagnostics.com/world-cancer-day-message-of-hope/ 2021-08-24T19:02:10+00:00 https://www.biomarkdiagnostics.com/a-good-choice-for-mmj-and-biotech-market-opportunity/ 2021-08-24T18:35:29+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2016/03/gaalen-engen-stockhouse-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2016/03/bill-good-stockhouse-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2016/03/bill-good-article-biomark-logo.png https://www.biomarkdiagnostics.com/wp-content/uploads/2016/03/stockhouse-biomark-graphic.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2016/03/vodis-pharmacueticals.png https://www.biomarkdiagnostics.com/stockhouse-com-and-biomark-interview-about-early-cancer-detection-podcast/ 2021-08-24T17:29:14+00:00 https://www.biomarkdiagnostics.com/a-supramolecular-indicator-displacement-assay-for-acetyl-amantadine/ 2021-08-24T17:15:57+00:00 https://www.biomarkdiagnostics.com/ai-early-diagnosis-could-save-heart-and-cancer-patients/ 2021-08-24T17:03:38+00:00 https://www.biomarkdiagnostics.com/opportunities-and-challenges-for-lung-cancer-screening-in-china/ 2021-08-24T16:55:45+00:00 https://www.biomarkdiagnostics.com/liquid-biopsy-what-is-it/ 2021-08-24T16:29:26+00:00 https://www.biomarkdiagnostics.com/biomarks-market-update-report/ 2021-08-24T16:25:42+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-advanced-raman-spectrometer-could-potentially-serve-as-complementary-detection-tool-for-covid-19-coronavirus/ 2021-08-24T16:11:33+00:00 https://www.biomarkdiagnostics.com/who-outlines-steps-to-save-7-million-lives-from-cancer/ 2021-08-24T15:42:37+00:00 https://www.biomarkdiagnostics.com/biomarks-liquid-biopsy-assay-levering-metabolomics-demonstrates-strong-performance-for-early-lung-cancer-detection/ 2021-08-24T15:42:13+00:00 https://www.biomarkdiagnostics.com/dr-horacio-bach-one-of-biomarks-scientific-advisor-and-expert-on-antibody-engineering-received-a-major-grant-from-cihr-for-covid-19-antibody-development/ 2021-08-24T15:30:30+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/IMG-20200331-WA0008.jpg https://www.biomarkdiagnostics.com/biomark-diagnostics-forms-new-company-bio-stream-diagnostics-inc-for-30-second-covid-19-screening/ 2021-08-24T15:30:15+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-inc-clarifies-prior-disclosure/ 2021-08-24T15:20:26+00:00 https://www.biomarkdiagnostics.com/bio-stream-diagnostics-inc-selected-for-cdl-rapid-response-innovation-program/ 2021-08-24T15:15:06+00:00 https://www.biomarkdiagnostics.com/biomark-receives-european-patent-for-cancer-diagnostic/ 2021-08-24T15:12:45+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-announces-peer-reviewed-publication-on-detection-of-cancer/ 2021-08-24T15:06:37+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-inc-receives-full-registered-trademark-status-from-the-us-patent-and-trademark-office-for-its-company-brand-name-biomark/ 2021-08-23T22:19:42+00:00 https://www.biomarkdiagnostics.com/biomarks-affiliated-company-bio-stream-diagnostics-inc-announces-partnership-with-qatar-university-ml-team-for-development-of-covid-19-testing/ 2021-08-23T22:19:27+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-expands-research-development-in-quebec/ 2021-08-23T22:19:12+00:00 https://www.biomarkdiagnostics.com/biomark-team-secures-health-canada-letter-of-no-objection-for-its-glioblastoma-clinical-trial/ 2021-08-23T22:18:57+00:00 https://www.biomarkdiagnostics.com/biomark-team-invited-for-full-application-for-sparks-grant-competition/ 2021-08-23T22:18:42+00:00 https://www.biomarkdiagnostics.com/biomark-appoints-dr-jean-francois-haince-as-strategic-advisor-to-guide-its-expansion-into-quebec/ 2021-08-23T22:18:15+00:00 https://www.biomarkdiagnostics.com/biomark-scientific-advisor-dr-donald-miller-to-present-at-the-delaware-valley-drug-metabolism-discussion-group/ 2021-08-23T21:03:14+00:00 https://www.biomarkdiagnostics.com/alfred-berkeley-joins-biomarks-advisory-team/ 2021-08-23T21:03:01+00:00 https://www.biomarkdiagnostics.com/biomark-retains-questrade-inc-to-provide-market-making-services/ 2021-08-23T21:02:44+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-targets-response-to-treatment-application-with-its-liquid-biopsy-platform/ 2021-08-23T21:02:30+00:00 https://www.biomarkdiagnostics.com/biomark-and-phytronix-technologies-inc-enter-into-a-collaborative-research-and-development-agreement/ 2021-08-23T20:53:43+00:00 https://www.biomarkdiagnostics.com/biomark-grants-options/ 2021-08-23T20:53:19+00:00 https://www.biomarkdiagnostics.com/biomarks-collaborator-receives-funding-to-validate-its-biomarker-panel-for-the-early-detection-of-lung-cancer/ 2021-08-23T20:52:56+00:00 https://www.biomarkdiagnostics.com/biomark-announces-exercise-of-warrants-and-gain-dtc-eligibility-for-its-common-shares/ 2021-08-23T20:52:40+00:00 https://www.biomarkdiagnostics.com/biomark-to-open-a-diagnostic-laboratory-in-quebec/ 2021-08-23T20:52:22+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/Dr-Haince.jpg https://www.biomarkdiagnostics.com/biomark-announces-change-of-auditor/ 2021-08-23T20:33:20+00:00 https://www.biomarkdiagnostics.com/biomark-to-expand-treatment-response-trial-to-advanced-lung-cancer-patient-receiving-immunotherapy/ 2021-07-15T16:07:46+00:00 https://www.biomarkdiagnostics.com/u-of-alberta-researchers-win-120k-grant-to-develop-metabolite-based-lung-cancer-test/ 2021-07-14T20:31:28+00:00 https://www.biomarkdiagnostics.com/10-reasons-why-biomark-bux-is-a-buy-and-long-term-hold/ 2021-06-01T22:13:44+00:00 https://www.biomarkdiagnostics.com/biomark-recoit-une-subvention-de-825-k-pour-developper-son-test-de-biopsie-liquide-pour-le-depistage-du-cancer-du-poumon/ 2021-06-01T12:32:00+00:00 https://www.biomarkdiagnostics.com/biomark-receives-825k-grant-to-develop-its-liquid-biopsy-assay-for-lung-cancer-screening/ 2021-06-01T12:35:00+00:00 https://www.biomarkdiagnostics.com/biomark-diagnostics-and-phytronix-technologies-strategic-technology-integration-partnership/ 2021-05-20T16:17:43+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/Dr-Haince.jpg https://www.biomarkdiagnostics.com/lung-cancer-screening-in-real-world-has-high-false-positive-rate/ 2021-05-19T21:32:06+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/medical-tubes-with-colorful-fluids-P2XQ7DJ.jpg https://www.biomarkdiagnostics.com/about-glioblastoma-gbm/ 2021-05-19T21:29:36+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/magnetic-resonance-imaging-PR8UWRY.jpg https://www.biomarkdiagnostics.com/cancer-risk-in-families/ 2021-05-19T21:27:21+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/pregnant-wife-suffering-from-cancer-PGAK7B5.jpg https://www.biomarkdiagnostics.com/biomarks-abstract-for-2019-asco-online-publication/ 2021-05-19T21:25:05+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/ASCO-ONLINE-Publication.png https://www.biomarkdiagnostics.com/national-research-team-targets-glioblastoma/ 2021-05-19T21:22:38+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/UoM-GBM-News.jpg https://www.biomarkdiagnostics.com/biomarks-liquid-biopsy-scientific-paper-to-be-featured-as-cover-on-cancers-upcoming-issue/ 2021-05-19T21:19:20+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2015/03/Cancer-Cover-e1566243667506.jpg https://www.biomarkdiagnostics.com/richmond-company-looking-for-holy-grail-in-covid-19-testing/ 2021-05-19T21:06:09+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2020/10/biomark-diagnostics-holy-grail-covid-19.jpg https://www.biomarkdiagnostics.com/doctors-fear-an-impending-wave-of-cancer-patients-after-covid-19-delays/ 2021-05-19T20:56:28+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/02/News-1130-logo.png https://www.biomarkdiagnostics.com/world-cancer-day-a-leading-international-awareness-day/ 2021-05-19T20:52:49+00:00 https://www.biomarkdiagnostics.com/missing-cancer-cases-a-worrying-pandemic-trend/ 2021-05-19T20:50:44+00:00 https://www.biomarkdiagnostics.com/cancer-that-went-undetected-during-the-pandemic-an-impending-disaster-specialists-warn/ 2021-05-19T20:48:16+00:00 https://www.biomarkdiagnostics.com/yearly-lung-cancer-scans-are-advised-for-people-50-and-over-with-shorter-smoking-histories/ 2021-05-19T20:46:04+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/03/A-computed-tomography-scan-of-lungs-805x503-1.jpg https://www.biomarkdiagnostics.com/3-cancer-diagnostic-stocks-to-watch-following-roches-genmark-buy/ 2021-05-19T20:36:43+00:00 https://www.biomarkdiagnostics.com/long-time-cardiologist-dr-myron-weisfeldt-who-changed-face-of-hopkins-receiving-american-heart-associations-distinguished-watkins-saunders-award-for-commitment-to-overcomin/ 2021-05-19T20:35:24+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/03/dr-mike-weisfeldt.png https://www.biomarkdiagnostics.com/wp-content/uploads/2021/03/Dr-Saunders.jpg https://www.biomarkdiagnostics.com/wp-content/uploads/2021/03/Dr-Watkins.jpg https://www.biomarkdiagnostics.com/a-simple-blood-test-to-detect-lung-cancer/ 2021-05-19T20:33:19+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/03/dr-david-wishart.jpg https://www.biomarkdiagnostics.com/alberta-research-to-spot-early-stage-lung-cancer/ 2021-05-19T20:31:07+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2021/04/david-wishart-genome-alberta-biomark-diagnostics.jpg https://www.biomarkdiagnostics.com/biomark-closes-second-tranche-of-private-placement-offering/ 2021-05-19T16:01:09+00:00 https://www.biomarkdiagnostics.com/biomark-raman-sensers-product-launch/ 2021-05-19T15:59:27+00:00 https://www.biomarkdiagnostics.com/wp-content/uploads/2014/09/IPS-and-Jim_sm.jpg https://www.biomarkdiagnostics.com/biomark-raman-sensers-product-launch-at-strategies-on-biophotonics-boston/ 2021-05-19T15:58:50+00:00 https://www.biomarkdiagnostics.com/biomark-announces-private-placement-offering/ 2021-05-19T15:55:51+00:00 https://www.biomarkdiagnostics.com/biomark-announces-private-placement/ 2021-05-19T15:54:54+00:00 https://www.biomarkdiagnostics.com/biomark-announces-private-placement-2/ 2021-05-19T15:54:02+00:00 https://www.biomarkdiagnostics.com/biomarks-scientific-advisor-named-dean-of-schulich-school-of-medicine-and-dentistry/ 2021-05-19T03:35:33+00:00 https://www.biomarkdiagnostics.com/biomark-announces-new-patent-granted-in-china/ 2021-05-19T03:29:03+00:00 https://www.biomarkdiagnostics.com/biomark-contributes-additional-scientific-publication/ 2021-05-19T03:28:38+00:00 https://www.biomarkdiagnostics.com/biomarks-abstract-accepted-for-2019-asco-online-publication/ 2021-05-19T03:28:10+00:00 https://www.biomarkdiagnostics.com/biomark-announces-the-private-placement/ 2021-05-19T03:27:47+00:00 https://www.biomarkdiagnostics.com/biomark-closes-the-private-placement-offering/ 2021-05-19T03:27:10+00:00 https://www.biomarkdiagnostics.com/biomark-and-its-team-of-collaborators-secure-chrp-funding/ 2021-05-19T03:26:43+00:00 https://www.biomarkdiagnostics.com/revision-on-total-funding-secured-by-biomark-and-its-team-of-collaborators-on-chrp-application/ 2021-05-19T03:26:16+00:00 https://www.biomarkdiagnostics.com/biomark-announces-new-patent-granted-in-united-states/ 2021-05-19T03:25:45+00:00 https://www.biomarkdiagnostics.com/biomark-announces-debt-settlement/ 2021-05-19T03:25:20+00:00